Discovery of a novel covalent non-β-lactam inhibitor of the metallo-β-lactamase NDM-1
- 1 July 2016
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 24 (13) , 2947-2953
Abstract
No abstract availableKeywords
Funding Information
- Tromsø Research Foundation
- Research Council of Norway (218539)
This publication has 26 references indexed in Scilit:
- Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant BacteriaJournal of Medicinal Chemistry, 2015
- Diaryl‐Substituted Azolylthioacetamides: Inhibitor Discovery of New Delhi Metallo‐β‐Lactamase‐1 (NDM‐1)ChemMedChem, 2014
- Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistanceNature, 2014
- Drug discovery considerations in the development of covalent inhibitorsBioorganic & Medicinal Chemistry Letters, 2014
- Metallo-β-lactamase: Inhibitors and reporter substratesBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2013
- Characterization of Purified New Delhi Metallo-β-lactamase-1Biochemistry, 2011
- Crystal structure of New Delhi metallo‐β‐lactamase reveals molecular basis for antibiotic resistanceProtein Science, 2011
- The resurgence of covalent drugsNature Reviews Drug Discovery, 2011
- NDM-1 — A Cause for Worldwide ConcernNew England Journal of Medicine, 2010
- Beyond Picomolar Affinities: Quantitative Aspects of Noncovalent and Covalent Binding of Drugs to ProteinsJournal of Medicinal Chemistry, 2008